Clinical trials have demonstrated that individuals using semaglutide for weight management can lose an average of 15% to 20% of their body weight over 68 weeks
Further solidifying 2025 as the year of updates to clinical frameworks, the European Association for the Study of Obesity released a new pharmacotherapy framework [3]
Slowing down the emptying of the stomach, which helps to control appetite and reduce food intake after meals
And the herbal wellness category continues to attract consumer interest, including products marketed using terms like "GLP-1 patch." If you are considering these options, here are some important things to keep in mind, no matter what you choose: Talk to your healthcare provider
Patients with a history of pancreatitis or uncontrolled gallstone disease should avoid these therapies
As part of his research, Anisimov also developed analogues of those peptide bioregulators, such as synthetic tetrapeptide epitalon